APA (7th ed.) Citation

Taga, H., Kishida, T., Inoue, Y., Yamamoto, K., Kotani, S., Masashi, T., . . . Mazda, O. (2023). TGF-β inhibitor treatment of H₂O₂-induced cystitis models provides biochemical mechanism for elucidating interstitial cystitis/painful bladder syndrome patients. PLoS ONE, 18(11), 1. https://doi.org/10.1371/journal.pone.0293983

Chicago Style (17th ed.) Citation

Taga, Hideto, Tsunao Kishida, Yuta Inoue, Kenta Yamamoto, Shin-ichiro Kotani, Tsujimoto Masashi, Osamu Ukimura, and Osam Mazda. "TGF-β Inhibitor Treatment of H₂O₂-induced Cystitis Models Provides Biochemical Mechanism for Elucidating Interstitial Cystitis/painful Bladder Syndrome Patients." PLoS ONE 18, no. 11 (2023): 1. https://doi.org/10.1371/journal.pone.0293983.

MLA (9th ed.) Citation

Taga, Hideto, et al. "TGF-β Inhibitor Treatment of H₂O₂-induced Cystitis Models Provides Biochemical Mechanism for Elucidating Interstitial Cystitis/painful Bladder Syndrome Patients." PLoS ONE, vol. 18, no. 11, 2023, p. 1, https://doi.org/10.1371/journal.pone.0293983.